StockViz
Share URL
Embed chart view
-
Export .csv
-
Download image
-
Copy link
-
Embed code
StockViz
RANKINGS
Zydus Lifesciences Limited
NSE:ZYDUSLIFE.NS
Sector
Location
Market Cap
USD 11.85 B
Share Price
USD 11.71
Avg Daily Volume
1,461,866
Change (1 day)
0.10%
Change (1 year)
-13.99%
Change (YTD)
3.15%
Zydus Lifesciences Limited Revenue for the year ending March 31, 2025: USD 2.72 B
Zydus Lifesciences Limited Revenue is USD 2.72 B for the year ending March 31, 2025, a 16.05% change year over year. Revenue is the total amount of money generated from the sales of goods or services by a company during a specific period.
-
Zydus Lifesciences Limited Revenue for the year ending March 31, 2024 was USD 2.34 B, a 14.12% change year over year.
-
Zydus Lifesciences Limited Revenue for the year ending March 31, 2023 was USD 2.05 B, a 5.16% change year over year.
-
Zydus Lifesciences Limited Revenue for the year ending March 31, 2022 was USD 1.95 B, a -3.53% change year over year.
-
Zydus Lifesciences Limited Revenue for the year ending March 31, 2021 was USD 2.02 B, a 10.44% change year over year.
Competitors
Mankind Pharma Limited
USD 28.53
MANKIND.NS
+0.89
3.23%
Ipsen S.A.
USD 121.82
IPN.PA
+1.67
1.39%
PT Kalbe Farma Tbk.
USD 0.09
KLBF.JK
-0.00
-1.29%
China Resources Double-Crane Pharmaceutical Co.,Ltd.
USD 2.64
600062.SS
+0.02
0.73%
Eli Lilly and Company
USD 780.67
LLY
+1.39
0.18%
AbbVie Inc.
USD 189.28
ABBV
-1.47
-0.77%
Novo Nordisk A/S
USD 71.08
NOVO-B.CO
+2.24
3.26%
Roche Holding AG
USD 347.79
RO.SW
+3.30
0.96%
Novartis AG
USD 123.46
NOVN.SW
+2.11
1.74%
Abbott Laboratories
USD 134.44
ABT
+0.33
0.25%
AstraZeneca PLC
USD 140.96
AZN.L
+1.64
1.18%
Merck & Co., Inc.
USD 80.93
MRK
-1.46
-1.77%
Thermo Fisher Scientific Inc.
USD 429.33
TMO
+1.57
0.37%
Amgen Inc.
USD 298.24
AMGN
+1.39
0.47%
Pfizer Inc.
USD 25.38
PFE
+0.06
0.24%
Gilead Sciences, Inc.
USD 111.75
GILD
+0.24
0.21%
Sanofi
USD 98.03
SAN.PA
+1.08
1.11%
Vertex Pharmaceuticals Incorporated
USD 459.62
VRTX
+2.59
0.57%
Bristol-Myers Squibb Company
USD 46.92
BMY
-0.71
-1.49%
Chugai Pharmaceutical Co., Ltd.
USD 49.30
4519.T
+0.76
1.57%
Key Data
| Date | Revenue | Revenue | Gross Profit | Operating Income |
|---|
Competitors
Mankind Pharma Limited
USD 28.53
MANKIND.NS
+0.89
3.23%
Ipsen S.A.
USD 121.82
IPN.PA
+1.67
1.39%
PT Kalbe Farma Tbk.
USD 0.09
KLBF.JK
-0.00
-1.29%
China Resources Double-Crane Pharmaceutical Co.,Ltd.
USD 2.64
600062.SS
+0.02
0.73%
Eli Lilly and Company
USD 780.67
LLY
+1.39
0.18%
AbbVie Inc.
USD 189.28
ABBV
-1.47
-0.77%
Novo Nordisk A/S
USD 71.08
NOVO-B.CO
+2.24
3.26%
Roche Holding AG
USD 347.79
RO.SW
+3.30
0.96%
Novartis AG
USD 123.46
NOVN.SW
+2.11
1.74%
Abbott Laboratories
USD 134.44
ABT
+0.33
0.25%
AstraZeneca PLC
USD 140.96
AZN.L
+1.64
1.18%
Merck & Co., Inc.
USD 80.93
MRK
-1.46
-1.77%
Thermo Fisher Scientific Inc.
USD 429.33
TMO
+1.57
0.37%
Amgen Inc.
USD 298.24
AMGN
+1.39
0.47%
Pfizer Inc.
USD 25.38
PFE
+0.06
0.24%
Gilead Sciences, Inc.
USD 111.75
GILD
+0.24
0.21%
Sanofi
USD 98.03
SAN.PA
+1.08
1.11%
Vertex Pharmaceuticals Incorporated
USD 459.62
VRTX
+2.59
0.57%
Bristol-Myers Squibb Company
USD 46.92
BMY
-0.71
-1.49%
Chugai Pharmaceutical Co., Ltd.
USD 49.30
4519.T
+0.76
1.57%